biote Corp. has recently seen a shift in its ownership landscape, as Bandera Partners LLC has disclosed a 2.5% stake in the company through a Schedule 13G/A filing. This development is noteworthy as it highlights the ongoing investment interest in the medicinal chemicals and botanical products sector.

Founded in Irving, Texas, biote Corp. operates in the medicinal chemicals and botanical products industry, classified under SIC code 2833. The company trades on the Nasdaq under the ticker symbol BTMD. It has been actively filing various reports with the SEC, including recent submissions such as a 10-Q and an 8-K.

The recent filing, dated November 12, 2026, reveals that Bandera Partners LLC, along with its partners Gregory Bylinsky and Jefferson Gramm, beneficially owns 707,067 shares of biote Corp.'s Class A common stock. This stake represents approximately 2.5% of the total shares outstanding, based on the company’s most recent quarterly report.

"This statement is filed by Bandera Partners LLC, a Delaware limited liability company... Bandera Partners is the investment manager of Bandera Master Fund L.P., a Cayman Islands exempted limited partnership," the filing states.

The filing indicates that Bandera Partners has the sole voting and dispositive power over the shares held by Bandera Master Fund, which may influence future decisions within biote Corp. Given the competitive nature of the medicinal chemicals industry, this investment could signal confidence in biote Corp.'s strategic direction and growth potential.

This update may affect various stakeholders, including current shareholders and potential investors, as it reflects a notable investment in biote Corp. and highlights the firm’s positioning within its industry. The disclosure also emphasizes the active role of investment firms in shaping the future of companies in the medicinal chemicals sector.

Looking ahead, it remains to be seen how this investment will impact biote Corp.'s operations and strategy. The filing does not specify any immediate next steps or actions to be taken by the company or its new stakeholders.